Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot/Feasibility Trial of 64Cu-DOTA-Daratumumab Positron Emission Tomography in Patients With Newly Diagnosed or Relapsed Multiple Myeloma

NCT03311828 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT03311828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03311828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot/Feasibility Trial of 64Cu-DOTA-Daratumumab Positron Emission Tomography in Patients With Newly Diagnosed or Relapsed Multiple Myeloma
Lead sponsor
City of Hope Medical Center
Phase
Phase 1
Overall status
Completed
Start date
February 21, 2018
Completion date
June 5, 2023
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

plasma cell myeloma, recurrent plasma cell myeloma, secondary amyloidosis